Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of Frailty.
Vart P, Butt JH, Jongs N, Schechter M, Chertow GM, Wheeler DC, Pecoits-Filho R, Langkilde AM, Correa-Rotter R, Rossing P, McMurray JJV, Heerspink HJL. Vart P, et al. Among authors: butt jh. J Gerontol A Biol Sci Med Sci. 2024 Feb 1;79(2):glad181. doi: 10.1093/gerona/glad181. J Gerontol A Biol Sci Med Sci. 2024. PMID: 37527836 Free PMC article. Clinical Trial.
Efficacy and safety of dapagliflozin according to aetiology in heart failure with reduced ejection fraction: insights from the DAPA-HF trial.
Butt JH, Nicolau JC, Verma S, Docherty KF, Petrie MC, Inzucchi SE, Schou M, Kosiborod MN, Langkilde AM, Martinez FA, Ponikowski P, Sabatine MS, Sjöstrand M, Solomon SD, Bengtsson O, Jhund PS, McMurray JJV, Køber L. Butt JH, et al. Eur J Heart Fail. 2021 Apr;23(4):601-613. doi: 10.1002/ejhf.2124. Epub 2021 Mar 10. Eur J Heart Fail. 2021. PMID: 33594755 Free PMC article. Clinical Trial.
Efficacy and Safety of Dapagliflozin in Men and Women With Heart Failure With Reduced Ejection Fraction: A Prespecified Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure Trial.
Butt JH, Docherty KF, Petrie MC, Schou M, Kosiborod MN, O'Meara E, Katova T, Ljungman CEA, Diez M, Ogunniyi MO, Langkilde AM, Sjöstrand M, Lindholm D, Bengtsson O, Martinez FA, Ponikowski P, Sabatine MS, Solomon SD, Jhund PS, McMurray JJV, Køber L. Butt JH, et al. JAMA Cardiol. 2021 Jun 1;6(6):678-689. doi: 10.1001/jamacardio.2021.0379. JAMA Cardiol. 2021. PMID: 33787831 Free PMC article. Clinical Trial.
Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus.
Yafasova A, Fosbøl EL, Schou M, Baslund B, Faurschou M, Docherty KF, Jhund PS, McMurray JJV, Sun G, Kristensen SL, Torp-Pedersen C, Køber L, Butt JH. Yafasova A, et al. Among authors: butt jh. J Am Coll Cardiol. 2021 Apr 13;77(14):1717-1727. doi: 10.1016/j.jacc.2021.02.029. J Am Coll Cardiol. 2021. PMID: 33832598 Free article.
Importance of diagnostic setting in determining mortality in patients with new-onset heart failure: temporal trends in Denmark from 1997 to 2017.
Arulmurugananthavadivel A, Holt A, Parveen S, Lamberts M, Gislason GH, Torp-Pedersen C, Madelaire C, Andersson C, Zahir D, Butt JH, Petrie MC, McMurray J, Fosbol EL, Kober L, Schou M. Arulmurugananthavadivel A, et al. Among authors: butt jh. Eur Heart J Qual Care Clin Outcomes. 2022 Oct 26;8(7):750-760. doi: 10.1093/ehjqcco/qcab073. Eur Heart J Qual Care Clin Outcomes. 2022. PMID: 34625809 Free PMC article.
Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA-HF.
Butt JH, Docherty KF, Jhund PS, de Boer RA, Böhm M, Desai AS, Howlett JG, Inzucchi SE, Kosiborod MN, Martinez FA, Nicolau JC, Petrie MC, Ponikowski P, Bengtsson O, Langkilde AM, Schou M, Sjöstrand M, Solomon SD, Sabatine MS, McMurray JJV, Køber L. Butt JH, et al. Eur J Heart Fail. 2022 Mar;24(3):513-525. doi: 10.1002/ejhf.2381. Epub 2021 Nov 24. Eur J Heart Fail. 2022. PMID: 34766424 Free PMC article. Clinical Trial.
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial.
Butt JH, Adamson C, Docherty KF, de Boer RA, Petrie MC, Inzucchi SE, Kosiborod MN, Maria Langkilde A, Lindholm D, Martinez FA, Bengtsson O, Schou M, O'Meara E, Ponikowski P, Sabatine MS, Sjöstrand M, Solomon SD, Jhund PS, McMurray JJV, Køber L. Butt JH, et al. Circ Heart Fail. 2021 Dec;14(12):e008837. doi: 10.1161/CIRCHEARTFAILURE.121.008837. Epub 2021 Nov 22. Circ Heart Fail. 2021. PMID: 34802253 Free article.
Temporal trends in initiation of mineralocorticoid receptor antagonists and risk of subsequent withdrawal in patients with heart failure: a nationwide study in Denmark from 2003-2017.
Zahir D, Bonde A, Madelaire C, Malmborg M, Butt JH, Fosbol E, Gislason G, Torp-Pedersen C, Andersson C, Rossignol P, McMurray JJV, Kober L, Schou M. Zahir D, et al. Among authors: butt jh. Eur J Heart Fail. 2022 Mar;24(3):539-547. doi: 10.1002/ejhf.2418. Epub 2022 Jan 17. Eur J Heart Fail. 2022. PMID: 34969178 Free article.
221 results